These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23732895)

  • 1. The evidence for use of pneumococcal conjugate over polysaccharide in children.
    Borrow R
    Hum Vaccin Immunother; 2013 Jun; 9(6):1385-6. PubMed ID: 23732895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines.
    Poolman J; Borrow R
    Expert Rev Vaccines; 2011 Mar; 10(3):307-22. PubMed ID: 21434799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal vaccination of older adults: conjugate or polysaccharide?
    Fedson DS; Guppy MJ
    Hum Vaccin Immunother; 2013 Jun; 9(6):1382-4. PubMed ID: 23732892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of pneumococcal polysaccharide vaccines: no simple answers.
    French N
    J Infect; 2003 Feb; 46(2):78-86. PubMed ID: 12634068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How many is enough? Will conjugated pneumococcal vaccines with more serotypes and fewer doses work better?
    Lu CY; Huang LM
    J Formos Med Assoc; 2011 Feb; 110(2):67-9. PubMed ID: 21377059
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of pneumococcal polysaccharide vaccine in children: what is the evidence?
    Borrow R; Heath PT; Siegrist CA
    Curr Opin Infect Dis; 2012 Jun; 25(3):292-303. PubMed ID: 22517603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants.
    Odutola A; Ota MOC; Antonio M; Ogundare EO; Saidu Y; Owiafe PK; Worwui A; Idoko OT; Owolabi O; Kampmann B; Greenwood BM; Alderson M; Traskine M; Swinnen K; Verlant V; Dobbelaere K; Borys D
    Vaccine; 2019 May; 37(19):2586-2599. PubMed ID: 30975570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
    O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D
    Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
    Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
    Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.
    Sorensen RU; Leiva LE; Giangrosso PA; Butler B; Javier FC; Sacerdote DM; Bradford N; Moore C
    Pediatr Infect Dis J; 1998 Aug; 17(8):685-91. PubMed ID: 9726341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal conjugate vaccines. A review.
    Galiza EP; Heath PT
    Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
    Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
    Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pneumococcal infections: Appraisal and perspectives in terms of adult vaccination].
    Baratali L; Lang PO
    Presse Med; 2015 Nov; 44(11):1155-61. PubMed ID: 26363530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of 7-valent pneumococcal conjugate vaccination in Germany: An analysis using the indirect cohort method.
    Rückinger S; van der Linden M; Reinert RR; von Kries R
    Vaccine; 2010 Jul; 28(31):5012-6. PubMed ID: 20546832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
    Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
    Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media.
    Eskola J
    Vaccine; 2000 Dec; 19 Suppl 1():S78-82. PubMed ID: 11163468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal vaccines.
    Ho CF; Lin TY
    Chang Gung Med J; 2005 Nov; 28(11):765-72. PubMed ID: 16422182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.